This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wong, S. C. C. Articles by Hsiao, W. L. W. Search for Related Content PubMed PubMed Citation Articles by Wong, S. C. C. Articles by Hsiao, W. L. W.

Prognostic and Diagnostic Significance of ß-Catenin Nuclear Immunostaining in Colorectal Cancer

¹ Biomedical Science, School of Chinese Medicine, Hong Kong Baptist University; ² Department of Biology, Hong Kong University of Science and Technology; and ³ Department of Pathology, Queen Elizabeth Hospital, Hong Kong, China

In the present study, we investigated the prognostic and diagnostic significance of ß-catenin nuclear immunostaining in 60 specimens of normal colorectal tissue; 180 specimens of colorectal polyps, adenomas, and carcinomas; and 40 specimens from patients with the simultaneous occurrence of polyps, adenomas, and carcinomas. Additional specimens from 59 patients with colorectal carcinoma and 14 patients with adenoma who subsequently developed carcinoma were examined for possible survival study. Immunohistochemical staining showed that the occurrence of nuclear ß-catenin correlated with the sequential stages in colorectal carcinogenesis, in which positive staining was observed in 0% of normal tissues, 8% of polyps, 92% of adenomas, and 100% of carcinomas. High immunohistochemical scores in colorectal carcinoma were significantly associated with lymph node metastasis and poor survival. Adenomas associated with synchronous or metachronous carcinomas showed significantly higher levels of nuclear ß-catenin compared with adenomas without associated carcinomas. Nuclear translocation of ß-catenin was rare or absent in other types of cytokeratin 20 positive adenocarcinomas examined (99 cases). Thus, it was positive in only 7% of colonic mucinous adenocarcinomas, 3% of pancreatic adenocarcinomas, 8% of ovarian mucinous cystadenocarcinomas, and 0% of gastric adenocarcinomas. However, 100% of primary and metastatic colorectal adenocarcinomas were positive for nuclear staining for ß-catenin. Thus, nuclear staining for ß-catenin may serve as an additional parameter to help distinguish colorectal adenocarcinomas from adenocarcinomas of other tissue sites. Collectively, the present large-scale study has clearly addressed the clinical significance of ß-catenin nuclear translocation with respect to tumor progression, survival, and differential diagnosis.

This article has been cited by other articles:

				S. C. C. Wong, C. M. L. Chan, B. B. Y. Ma, E. P. Hui, S. S. M. Ng, P. B. S. Lai, M. T. Cheung, E. S. F. Lo, A. K. C. Chan, M. Y. Y. Lam, et al. Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients Clin. Cancer Res., February 1, 2009; 15(3): 1005 - 1012. [Abstract] [Full Text] [PDF]

				A. J. Chien, E. C. Moore, A. S. Lonsdorf, R. M. Kulikauskas, B. G. Rothberg, A. J. Berger, M. B. Major, S. T. Hwang, D. L. Rimm, and R. T. Moon Activated Wnt/ss-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model PNAS, January 27, 2009; 106(4): 1193 - 1198. [Abstract] [Full Text] [PDF]

				M. Suzuki, H. Shigematsu, T. Nakajima, R. Kubo, S. Motohashi, Y. Sekine, K. Shibuya, T. Iizasa, K. Hiroshima, Y. Nakatani, et al. Synchronous Alterations of Wnt and Epidermal Growth Factor Receptor Signaling Pathways through Aberrant Methylation and Mutation in Non Small Cell Lung Cancer Clin. Cancer Res., October 15, 2007; 13(20): 6087 - 6092. [Abstract] [Full Text] [PDF]

				S. Urakami, H. Shiina, H. Enokida, T. Kawakami, T. Tokizane, T. Ogishima, Y. Tanaka, L.-C. Li, L. A. Ribeiro-Filho, M. Terashima, et al. Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Cancer through Aberrant Canonical Wnt/{beta}-Catenin Signaling Pathway Clin. Cancer Res., January 15, 2006; 12(2): 383 - 391. [Abstract] [Full Text] [PDF]